Devonian Health Group Inc
- LAST PRICE0.1300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.1200/ 29
- Ask / Lots0.1500/ 26
- Open / Previous Close--- / 0.1300
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Devonian Health Group Inc | 19.3M | -6.0x | --- |
Pharmather Holdings Ltd | 19.0M | -9.0x | --- |
Kane Biotech Inc | 13.8M | -2.5x | --- |
Cytophage Technologies Ltd | 13.5M | -0.8x | --- |
BioNxt Solutions Inc | 26.6M | -3.9x | --- |
Preveceutical Medical Inc | 10.8M | -8.5x | --- |
Company Information
Devonian Health Group Inc. is a Canada-based late-stage botanical pharmaceutical company. The Company is focused on developing prescription botanical drugs from plant materials and algae for the treatment of inflammatory autoimmune diseases, including but not limited to ulcerative colitis and atopic dermatitis. It is also involved in the development of high-value cosmeceutical products leveraging the same proprietary approach employed with their pharmaceutical offerings. Its flagship product, Thykamine, is a pharmaceutical product issued from its SUPREX platform, for the prevention and treatment of health conditions related to inflammation and oxidative stress, including ulcerative colitis, atopic dermatitis, psoriasis, and other autoimmune diseases. Its cosmeceutical products include R-Spinasome and Purgenesis. Its subsidiary, Altius Healthcare Inc., is focused on selling prescription pharmaceutical products in Canada, under license from brand name pharmaceutical companies.
Contact Information
- Headquarters
- 360 rue des EntrepreneursMONTMAGNY, QC, Canada G5V 4T1
- Phone
- 514-248-7509
- Fax
- 450-937-6696
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $19.3M |
|---|---|
Revenue (TTM) | $9.8M |
Shares Outstanding | 148.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.25 |
EPS | $-0.02 |
Book Value | $0.10 |
P/E Ratio | -6.0x |
Price/Sales (TTM) | 2.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -32.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
